These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15757604)

  • 21. Stent-related cardiac events after non-cardiac surgery: drug-eluting stent vs. bare metal stent.
    Kim HL; Park KW; Kwak JJ; Kim YS; Sir JJ; Lee SJ; Lee HY; Chang HJ; Kang HJ; Cho YS; Chung WY; Chae IH; Choi DJ; Kim HS; Oh BH; Park YB; Koo BK
    Int J Cardiol; 2008 Jan; 123(3):353-4. PubMed ID: 17346821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet reactivity in patients with subacute stent thrombosis compared with non-stent-related acute myocardial infarction.
    Lev EI; Alviar CL; Arikan ME; Dave BP; Granada JF; DeLao T; Tellez A; Maresh K; Kleiman NS
    Am Heart J; 2007 Jan; 153(1):41.e1-6. PubMed ID: 17174635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Staged carotid artery stenting and coronary artery bypass graft surgery: initial results from a single center.
    Kovacic JC; Roy PR; Baron DW; Muller DW
    Catheter Cardiovasc Interv; 2006 Jan; 67(1):142-8. PubMed ID: 16342270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlation between prior coronary revascularization and perioperative cardiac events in patients for noncardiac surgery].
    Baba T; Goto T; Tanabe Y; Shibata Y; Homma K
    Masui; 2000 Nov; 49(11):1210-6. PubMed ID: 11215226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
    Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
    Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal trends in major angioplasty complications: technical issues and the case for on-site coronary surgery.
    Mishra KJ; Sage PR; Philpott AC; Zeitz CJ; Horowitz JD
    Intern Med J; 2006 Jul; 36(7):458-61. PubMed ID: 16780454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of stenting for unprotected left main coronary artery disease in 297 patients.
    Han YL; Wang SL; Jin QM; Liu HW; Ma YY; Wang ZL; Wang DM; Luan B; Wang G
    Chin Med J (Engl); 2006 Apr; 119(7):544-50. PubMed ID: 16620694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catastrophic outcomes of noncardiac surgery soon after coronary stenting.
    Kałuza GL; Joseph J; Lee JR; Raizner ME; Raizner AE
    J Am Coll Cardiol; 2000 Apr; 35(5):1288-94. PubMed ID: 10758971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry).
    Feldman DN; Gade CL; Slotwiner AJ; Parikh M; Bergman G; Wong SC; Minutello RM;
    Am J Cardiol; 2006 Nov; 98(10):1334-9. PubMed ID: 17134624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.
    Mercado N; Wijns W; Serruys PW; Sigwart U; Flather MD; Stables RH; O'Neill WW; Rodriguez A; Lemos PA; Hueb WA; Gersh BJ; Booth J; Boersma E
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):512-9. PubMed ID: 16077421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.
    Marcucci R; Paniccia R; Antonucci E; Gori AM; Fedi S; Giglioli C; Valente S; Prisco D; Abbate R; Gensini GF
    Am J Cardiol; 2006 Nov; 98(9):1156-9. PubMed ID: 17056317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents.
    Bertrand OF; Faurie B; Larose E; Nguyen CM; Gleeton O; Déry JP; Noël B; Proulx G; Roy L; Costerousse O; De Larochellière R; Rodés-Cabau J
    J Invasive Cardiol; 2008 Mar; 20(3):99-104. PubMed ID: 18316823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timing of thrombotic events in patients receiving 2 weeks of clopidogrel therapy post bare metal coronary artery stenting: a New Zealand retrospective study.
    Tie S; Wong CK; Yap J; Wilkins G; Williams M; Kay P
    N Z Med J; 2007 Jun; 120(1255):U2553. PubMed ID: 17546101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transradial primary angioplasty and stenting in Indian patients with acute myocardial infarction: acute results and 6-month follow-up.
    Ranjan A; Patel TM; Shah SC; Malhotra H; Patel R; Vayada N; Pothiwala R; Fonseca K; Tanwar NS
    Indian Heart J; 2005; 57(6):681-7. PubMed ID: 16521638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial.
    Kelbaek H; Kløvgaard L; Helqvist S; Lassen JF; Krusell LR; Engstrøm T; Bøtker HE; Jørgensen E; Saunamäki K; Aljabbari S; Thayssen P; Galløe A; Jensen GV; Thuesen L
    J Am Coll Cardiol; 2008 May; 51(21):2011-6. PubMed ID: 18498953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of death or myocardial infarction by exercise single photon emission computed tomography perfusion scintigraphy in patients who have had recent coronary artery stenting.
    Rajagopal V; Gurm HS; Brunken RC; Pothier CE; Bhatt DL; Lauer MS
    Am Heart J; 2005 Mar; 149(3):534-40. PubMed ID: 15864244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of bleeding complications associated with glycoprotein IIb/IIIa receptors blockade in patients with high-risk acute coronary syndromes: insights from the PRISM-PLUS study.
    Huynh T; Piazza N; DiBattiste PM; Snapinn SM; Wan Y; Pharand C; Theroux P
    Int J Cardiol; 2005 Apr; 100(1):73-8. PubMed ID: 15820288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcomes in treating left main trifurcation coronary artery disease with the Paclitaxel-eluting stent.
    Shammas NW; Dippel EJ; Avila A; Gehbauer L; Farland L; Brosius S; Jerin M; Winter M; Stoakes P; Byrd J; Majetic L; Shammas G; Sharis P; Robken J
    J Invasive Cardiol; 2007 Feb; 19(2):77-82. PubMed ID: 17268042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased complication rates using the transradial compared to the transfemoral approach in percutaneous coronary intervention in the era of routine stenting and glycoprotein platelet IIb/IIIa inhibitor use: a large single-center experience.
    Eichhöfer J; Horlick E; Ivanov J; Seidelin PH; Ross JR; Ing D; Daly P; Mackie K; Ridley B; Schwartz L; Barolet A; Dzavík V
    Am Heart J; 2008 Nov; 156(5):864-70. PubMed ID: 19061699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.